Akhil Sood

Joining the discussion are David Liu, a rheumatologist from Melbourne, and Akhil Sood, a fellow at Stanford with expertise in lupus treatment. They dive into groundbreaking studies from the ACR Annual Meeting, spotlighting promising results for Dapirulizumab in lupus care. The conversation shifts to new therapies and the clinical implications for lupus and advancements in AI for diagnosing inflammatory conditions. They also address the risks of steroid use in rheumatic diseases and the emerging management challenges faced by patients.